Lista de obras - Corrine K. Welt - Dominio Público Uruguay

A genetic basis for functional hypothalamic amenorrhea

artículo científico publicado en 2011

A patient's guide: polycystic ovary syndrome (PCOS).

artículo científico publicado en 2014

Activin Regulates βA-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells* ⬇️

artículo científico publicado el 1 de marzo de 1998

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis

artículo científico publicado en 2013

Autoimmune oophoritis in the adolescent.

scientific article published on January 2008

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome

artículo científico publicado en 2015

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

artículo científico publicado en 2006

Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome

artículo científico publicado en 2013

Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

artículo científico publicado en 2013

Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism

artículo científico publicado en 2006

Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

artículo científico publicado en 2015

Control of estradiol secretion in reproductive ageing

artículo científico publicado en 2006

Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition

artículo científico publicado en 2003

Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

artículo científico publicado en 2016

Corrigendum: Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis.

artículo científico publicado en 2017

Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

artículo científico publicado en 2009

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations

artículo científico publicado en 2006

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

artículo científico publicado en 2013

Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development

artículo científico publicado en 2001

Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles

artículo científico publicado en 2001

Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome ⬇️

artículo científico publicado el 1 de enero de 2012

Evaluating reported candidate gene associations with polycystic ovary syndrome ⬇️

artículo científico publicado el 30 de enero de 2013

Evidence of early ovarian aging in fragile X premutation carriers

artículo científico publicado en 2004

Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

artículo científico publicado en 2013

Female reproductive aging is marked by decreased secretion of dimeric inhibin

artículo científico publicado en 1999

Fertility preservation in female classic galactosemia patients

artículo científico publicado en 2013

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

artículo científico publicado en 2005

Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women

scientific article published on 01 August 1997

Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.

artículo científico publicado en 2015

Genetics of polycystic ovary syndrome

artículo científico publicado en 2014

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

artículo científico publicado en 2015

Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance

artículo científico publicado en 2015

Identification of subjects with polycystic ovary syndrome using electronic health records.

artículo científico publicado en 2015

Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer

artículo científico publicado en 1998

Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function

artículo científico publicado en 2011

Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.

artículo científico publicado en 2013

Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model

artículo científico publicado en 1998

Isolated Prolactin Deficiency Associated With Serum Autoantibodies Against Prolactin-Secreting Cells ⬇️

artículo científico publicado el 12 de agosto de 2013

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

artículo científico publicado en 2018

Leptin and soluble leptin receptor in follicular fluid.

artículo científico publicado en 2003

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study

artículo científico publicado en 2014

Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls.

artículo científico publicado en 2011

Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome

scientific article published on 01 August 2006

Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes ⬇️

artículo científico publicado el 3 de marzo de 2012

Primary ovarian insufficiency: a more accurate term for premature ovarian failure.

artículo científico publicado en 2007

Prolactin suppresses GnRH but not TSH secretion

artículo científico publicado en 2005

Recombinant human leptin in women with hypothalamic amenorrhea.

artículo científico publicado en 2004

Recombinant human prolactin for the treatment of lactation insufficiency.

artículo científico publicado en 2010

Recurrent hypoglycemia does not impair the cortisol response to adrenocorticotropin infusion in healthy humans

artículo científico publicado en 1998

Regulation and function of inhibins in the normal menstrual cycle.

artículo científico publicado en 2004

Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure

artículo científico publicado en 2004

Responsiveness to a Physiological Regimen of GnRH Therapy and Relation to Genotype in Women With Isolated Hypogonadotropic Hypogonadism ⬇️

artículo científico publicado el 22 de enero de 2013

Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels

artículo científico publicado en 2005

Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea

artículo científico publicado en 2007

Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

artículo científico publicado en 2012

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone

artículo científico publicado en 2002

Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.

artículo científico publicado en 2014

Skeletal health in adult patients with classic galactosemia

artículo científico publicado en 2012

Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome

artículo científico publicado en 2001

The adult galactosemic phenotype

artículo científico publicado en 2011

The male reproductive system in classic galactosemia: cryptorchidism and low semen volume

artículo científico publicado en 2012

The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction

scientific article (publication date: June 2002)

Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis

artículo científico publicado en 2017

Will leptin become the treatment of choice for functional hypothalamic amenorrhea?

artículo científico publicado en 2007

Lista de obras de Corrine K. Welt

A genetic basis for functional hypothalamic amenorrhea

A patient's guide: polycystic ovary syndrome (PCOS).

Activin Regulates βA-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells* ⬇️

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis

Autoimmune oophoritis in the adolescent.

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome

Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism

Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

Control of estradiol secretion in reproductive ageing

Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition

Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Corrigendum: Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis.

Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development

Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles

Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome ⬇️

Evaluating reported candidate gene associations with polycystic ovary syndrome ⬇️

Evidence of early ovarian aging in fragile X premutation carriers

Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Female reproductive aging is marked by decreased secretion of dimeric inhibin

Fertility preservation in female classic galactosemia patients

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women

Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.

Genetics of polycystic ovary syndrome

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance

Identification of subjects with polycystic ovary syndrome using electronic health records.

Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer

Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function

Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.

Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model

Isolated Prolactin Deficiency Associated With Serum Autoantibodies Against Prolactin-Secreting Cells ⬇️

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

Leptin and soluble leptin receptor in follicular fluid.

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study

Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls.

Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome

Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes ⬇️

Primary ovarian insufficiency: a more accurate term for premature ovarian failure.

Prolactin suppresses GnRH but not TSH secretion

Recombinant human leptin in women with hypothalamic amenorrhea.

Recombinant human prolactin for the treatment of lactation insufficiency.

Recurrent hypoglycemia does not impair the cortisol response to adrenocorticotropin infusion in healthy humans

Regulation and function of inhibins in the normal menstrual cycle.

Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure

Responsiveness to a Physiological Regimen of GnRH Therapy and Relation to Genotype in Women With Isolated Hypogonadotropic Hypogonadism ⬇️

Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels

Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea

Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone

Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.

Skeletal health in adult patients with classic galactosemia

Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome

The adult galactosemic phenotype

The male reproductive system in classic galactosemia: cryptorchidism and low semen volume

The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction

Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis

Will leptin become the treatment of choice for functional hypothalamic amenorrhea?